IMIQUAD 12.5MG CREAM contains Imiquimod which belongs to the group of medicines called Immune response modifiers. IMIQUAD 12.5MG CREAM is used to manage actinic keratosis, which is a precancerous condition that occurs as a rough, scaly patch on the skin due to years of sun exposure in affected individuals.
IMIQUAD 12.5MG CREAM is not recommended for use in patients allergic to Imiquimod. It is also not recommended for use in patients with an unhealed management site (which is under management with other medicines).
Before applying IMIQUAD 12.5MG CREAM, inform your doctor if you have previously used the same medicine, and/or suffering from autoimmune disorders (disease where body’s own defense system attacks its own cells) or abnormal blood count.
IMIQUAD 12.5MG CREAM should be used with caution during pregnancy and in women planning for pregnancy only if it is clearly necessary. It is not recommended for use in breastfeeding women as it is not known whether the medicine gets secreted through breast milk.
IMIQUAD 12.5MG CREAM is not recommended for use in children and adolescents (aged below 18 years) and is advised to be used with caution in elderly patients (aged 60 years and above) after consulting the doctor.
The most common side effects of applying IMIQUAD 12.5MG CREAM are itchy skin, pain, burning/ irritation (at the applied site), redness of skin, headache, nausea, muscle/joint pain, and/or tiredness. Consult your doctor if any of these symptoms worsens.
No content available
